The Report “Asia Pacific Biopreservation Media Market, By Type (Home-brew Media, Pre-formulated Media), By Application (Regenerative Medicines, Drug Discovery, Biobanking), By Country (Japan, China, India, Republic of Korea, Australia) - Analysis and Forecasts to 2021” is estimated to grow to around $147.0 million by 2021, at a CAGR of 21.2% between 2016 and 2021.
Browse through the TOC of the Asia Pacific Biopreservation Media Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report
Biopreservation is a vital method for the stabilization of natural and engineered tissues to permit transportation and extended shelf life. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation, and banking. These specimens can be cells, tissues and organs, macromolecules, fungi, viruses, and bacteria. Biopreservation maintains the integrity and functionality of cells outside the native environment for extended storage times.
Due to the growing population and prevalence of various diseases, the APAC region in the global biopreservation media market has a huge potential for growth. The increase in demand for organ transplantation due to aging population, rising incidence rate of lifestyle diseases like obesity, diabetes etc., and smoking leading to organ failure, and the advances in the organ preservation solutions are projected to propel the bio-preservation market demand. Moreover, high demand of cell-banking system like umbilical cord blood-banking, adult stem banking, and umbilical cell-banking are contributing to this booming industry.
The demand for biopreservation storage media is expected to be fuelled by human tissue biobanking, which is of particular importance for implementation of novel biomarkers into clinical trials. Regenerative medicine focuses on both regenerating damaged tissues and organs in the body as well as growing tissues and organs in the laboratory and then implanting them in the body. Biobanking is a technique similar to biorepository that stores the biological samples of human beings. The global biopreservation storage media market is expected to receive impetus from rapid advancements in biobanking technology.
The key market players of the global biopreservation market include Lifeline Scientific Inc. (U.S.), BioLife Solutions Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Wak-Chemie Medical GmbH (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), and others. This market is segmented and forecasted on the basis of type, application, and geography.
The types comprise home-brew and pre-formulated media where home-brew media is dominating the market while the applications consist of regenerative medicines, biobanking, and drug discovery. Based on application, it is segmented into regenerative medicine, drug discovery and biobanking. Report covers major countries which includes Japan, China, India, Republic of Korea, and Australia.
This report also includes the market share and value chain analyses as well as market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Priyank Tiwari
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
